Company Profile

AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo
BSE902.65-27.25 (-2.93 % )
PREV CLOSE (Rs.) 929.90
OPEN PRICE (Rs.) 930.15
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 56317
TODAY'S LOW / HIGH (Rs.)897.80 937.95
52 WK LOW / HIGH (Rs.)281.15 996.65
NSE902.25 -27.75 (-2.98 % )
PREV CLOSE(Rs.) 930.00
OPEN PRICE (Rs.) 935.00
BID PRICE (QTY) 902.25 (99 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 2019465
TODAY'S LOW / HIGH(Rs.) 897.50 938.00
52 WK LOW / HIGH (Rs.)288.85 996.85

Company Profile

Financial ratio

Particulars Mar  2020 Mar  2019 Mar  2018 Mar  2017 Mar  2016
Operational & Financial Ratios          
   Earnings Per Share (Rs) 48.32 40.36 41.36 39.28 34.61
   CEPS(Rs) 65.05 51.71 50.82 46.49 41.26
   DPS(Rs) 3.00 2.50 2.50 2.50 2.50
   Book NAV/Share(Rs) 286.92 237.08 199.36 159.96 124.50
   Tax Rate(%) 24.31 23.53 25.27 24.86 26.28
Margin Ratios          
   Core EBITDA Margin(%) 10.29 9.86 22.86 22.76 22.85
   EBIT Margin(%) 8.60 8.36 20.10 20.69 21.49
   Pre Tax Margin(%) 7.95 7.70 19.62 20.25 19.65
   PAT Margin (%) 6.02 5.89 14.67 15.22 14.49
   Cash Profit Margin (%) 8.07 7.56 18.05 18.05 17.30
Performance Ratios          
   ROA(%) 10.34 10.00 13.07 14.44 14.13
   ROE(%) 18.53 18.47 22.99 27.57 32.51
   ROCE(%) 18.80 17.97 22.72 24.92 27.35
   Asset Turnover(x) 1.72 1.70 0.89 0.95 0.98
   Sales/Fixed Asset(x) 4.12 4.36 2.44 2.96 2.79
   Working Capital/Sales(x) 9.40 12.11 4.70 5.80 5.69
Efficiency Ratios          
   Fixed Capital/Sales(x) 0.24 0.23 0.41 0.34 0.36
   Receivable days 29.85 29.56 64.66 89.16 106.53
   Inventory Days 57.72 59.64 112.70 101.43 100.27
   Payable days 52.98 58.56 67.77 75.73 81.50
Valuation Parameters          
   PER(x) 8.55 19.47 13.47 17.19 21.53
   PCE(x) 6.35 15.20 10.96 14.52 18.06
   Price/Book(x) 1.44 3.32 2.80 4.22 5.98
   Yield(%) 0.73 0.32 0.45 0.37 0.34
   EV/Net Sales(x) 1.17 2.61 2.20 2.84 3.47
   EV/Core EBITDA(x) 5.32 12.43 9.33 11.95 14.10
   EV/EBIT(x) 6.63 15.24 10.90 13.58 15.95
   EV/CE(x) 0.94 1.94 1.73 2.64 3.04
   M Cap / Sales 1.05 2.35 1.98 2.65 3.16
Growth Ratio          
   Net Sales Growth(%) 18.07 18.83 10.42 8.08 13.81
   Core EBITDA Growth(%) 23.10 6.03 9.11 4.67 27.50
   EBIT Growth(%) 21.25 1.07 6.19 4.10 28.86
   PAT Growth(%) 20.45 -2.40 5.38 13.55 28.70
   EPS Growth(%) 19.72 -2.41 5.28 13.52 -35.87
Financial Stability Ratios          
   Total Debt/Equity(x) 0.33 0.50 0.41 0.36 0.69
   Current Ratio(x) 1.44 1.28 1.41 1.39 1.31
   Quick Ratio(x) 0.77 0.67 0.73 0.74 0.80
   Interest Cover(x) 13.32 12.76 42.66 46.80 11.69
   Total Debt/Mcap(x) 0.23 0.15 0.15 0.09 0.12